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:\ CRl:CIAL intraoperative period during ortho-
topic liver transplantation occurs during mobili-
zation of the diseased recipient liver prior to he-
patectomy and during the subsequent anhepatic 
phase of the hepatectomy and implantation of the 
new liver. During this time, obstruction of the 
portal vein and inferior vena cava can result in a 
fall in cardiac output and arterial pressure (1), 
consequent hypoperfusion of critical organs, 
damage to the engorged subdiaphragmatic capil-
lary beds and extensive bleeding from high pres~ 
sure venous collaterals. These non physiologic 
conditions have been responsible for intraopera-
tive or delayed deaths and have contributed to the 
lack of wide application of replacement of the li- . 
ver (2). -
When orthotopic liver transplantation was 
developed in dogs, bypass techniques were used to 
shunt blood from the lower to the upper half of 
the body without pumps and systemic heparini-
zation (3,4). The clinical application of the pas-
sive bypass resulted in the formation of clots in 
the tubing with the consequent passage of multi-
ple "emboli" to the lungs (5). The use of a pump 
driven bypass under systemic heparinization was 
discouraged by major difficulties in reversing the 
heparin effect in patients with endstage hepatic 
disease and multiple pre-existing coasulation de-
fects (2. 6, 7). We report herein upon a pump 
driven nonheparin bypass system that was tested 
in dogs and was subsequently applied in 23 
patients who underwent replacement of the 
liver. 
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TECHNIQUE 
The unique components of the circuit include 
modified heparin bonded Gott aneurysm shunt 
tubing (Argyle Division, Sherwood Medical) for 
drainage and return cannulae, plus a centrifugal 
blood pump (Bio-Medicus, Inc.). The cannula to 
drain blood from the-.inferior vena cava is ad-
vanced through the saphenofemoral venous junc-
tion to near the confluence of the common iliac 
veins (Fig. 1). The·_ cannula which removes 
splanchnic blood is placed end-on into th~ tran-
sected portal vein (Fig. 1). The fusiform Gott 
shunts which are 60 centimeters long with an ex-
tra side hole at one end, are i-deal for dra,inage. 
After intravascular insertion, these cannulae are 
cut where their diameter is large and joined to-
gether with a three-eighths inch polished stainless 
steel Y type connector _ (Fig. 1). The blood is 
drained to a centrifugal pump which returns the 
effluent to the ipsilateral axillary vein (Fig. 1) 
through a 7 or 9 millimeter Gott cannula without 
a side hole. Connections of the cannulae to the 
blood pump and a flow ~ter are made with short 
segments of uncoated three-eighths inch_poly-
vinyl chloride tubing. -
The entire circuit may be primed and debub-
bled on the operative field. After connecti~g the 
sterilized components,. the drainage cannube are 
submerged in a basin of sali~e solution. A regu-
lated wall suction is then applitd. to the tip of the 
return cannula so that priming is completed as 
the saline solution is drawn through the circuit 
components. The disposable blood pump head 
may then be passed off the field and connected to 
its motor console. Alternatively, the cannulae 
may be individually primed by a bulb type 
syringe and connected to the remainder of the 
circuit which has been primed by the extracor-
poreal perfusion team in a closed loop manner. 
While the former method does not require input 
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from a perfusionist, the latter has caused the least 
operative interruption and is currently preferred. 
The rotation of the centrifugal blood pump is 
adjusted to deliver the maximum blood return at 
the minimal revolutions per minute. In adults, 
total flow has averaged 4 liters per minute and 
has ranged between 1.5 and 6.0 liters. In many 
patients, the portal circulation has contributed 
more than one-half of the total flow. The veno-
venous bypass has often been initiated prior to 
extensive retrohepatic resection, and its average 
duration of 100 minutes (a range of 70 to 158) 
has, therefore, included the time required for 
completion of recipient hepatectomy plus im-
plantation of the donor graft. 
Venous reservoirs are not needed in this 
system. All circuit tubing is shortened as much as 
possible to minimize exposure to foreign surfaces. 
Except for the rare formation of fine fibrin 
strands on the rims of the connectors and on the 
pump cone supports, there has been no evidence 
of ex vivo thrombosis. In one patient, a soft iliac 
vein thrombosis was removed with the drainage 
. cannula, but there has been no clinical or autopsy 
evidence in any patient of venous embolism. 
Component blood replacement during the period 
of bypass has actually improved the pre-existing 
coagulopathy --during the bypass in spite of a 
tendency for the'. platelet counts to fall during this 
time. _ 
So far, this system has been used only in adults. 
Children have been 'found to tolerate the com-
bined portal and venacaval occlusion far better 
than adults, and it is possible that the system 
should be used in younger liver recipients only 
~ otume 100 
when indicated by vasomotor instability durin~ 
test cross clamping. In adults, the advantages 01 
the bypass are so great that it has become a rou· 
tine part of transplantation of the liver. 
pt:~fMAov 
A technique of veno-venous bypass without 
heparin has been developed for use during tht 
anhepatic phase of transplantation of the liver. 
With this method, the ability to compress the 
temporarily obstructed vena caval and portal ve-
nous systems has made hepatic transplantation an 
easier procedure. 
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FIG. 1. Anhepatic stage of transplantation of the liver with cavoportal to axillary bypass circuit. 
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